LncRNA GLTC Targets LDHA for Succinylation and Enzymatic Activity to Promote Progression and Radioiodine Resistance in Papillary Thyroid Cancer

Overview

Journal Cell Death Differ

Specialty Cell Biology

Date 2023 Apr 8

PMID 37031273

Authors

Liang Shi

Rui Duan

Zhenhua Sun

Qiong Jia

Wenyu Wu

Feng Wang

Jianjun Liu

Hao Zhang

Xue Xue

Affiliations

Soon will be listed here.

Abstract

Dysregulation of long noncoding RNAs (lncRNAs) has been associated with the development and progression of many human cancers. Lactate dehydrogenase A (LDHA) enzymatic activity is also crucial for cancer development, including the development of papillary thyroid cancer (PTC). However, whether specific lncRNAs can regulate LDHA activity during cancer progression remains unclear. Through screening, we identified an LDHA-interacting lncRNA, GLTC, which is required for the increased aerobic glycolysis and cell viability in PTC. GLTC was significantly upregulated in PTC tissues compared with nontumour thyroid tissues. High expression of GLTC was correlated with more extensive distant metastasis, a larger tumour size, and poorer prognosis. Mass spectrometry revealed that GLTC, as a binding partner of LDHA, promotes the succinylation of LDHA at lysine 155 (K155) via competitive inhibition of the interaction between SIRT5 and LDHA, thereby promoting LDHA enzymatic activity. Overexpression of the succinylation mimetic LDHA mutant restored glycolytic metabolism and cell viability in cells in which metabolic reprogramming and cell viability were ceased due to GLTC depletion. Interestingly, GLTC inhibition abrogated the effects of K155-succinylated LDHA on radioiodine (RAI) resistance in vitro and in vivo. Taken together, our results indicate that GLTC plays an oncogenic role and is an attractive target for RAI sensitisation in PTC treatment.

Citing Articles

CPT1A mediates succinylation of LDHA at K318 site promoteing metabolic reprogramming in NK/T-cell lymphoma nasal type.

Tian H, Ge Y, Yu J, Chen X, Wang H, Cai X Cell Biol Toxicol. 2025; 41(1):42.

PMID: 39934546 PMC: 11814014. DOI: 10.1007/s10565-025-09994-6.

Lactate and lactylation in cancer.

Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y Signal Transduct Target Ther. 2025; 10(1):38.

PMID: 39934144 PMC: 11814237. DOI: 10.1038/s41392-024-02082-x.

Long noncoding RNA FAM111A-DT promotes aggressiveness of papillary thyroid cancer via activating NF-κB signaling.

Chen J, Chen Y, Rong H, Huang R, Zhang P, Huo Z J Endocrinol Invest. 2025; .

PMID: 39786708 DOI: 10.1007/s40618-025-02531-6.

Hypoxic mesenchymal stem cell-derived exosomal circDennd2a regulates granulosa cell glycolysis by interacting with LDHA.

Li W, Lu M, Shang J, Zhou J, Lin L, Liu Y Stem Cell Res Ther. 2024; 15(1):484.

PMID: 39695793 PMC: 11657290. DOI: 10.1186/s13287-024-04098-0.

YTHDF1 boosts the lactate accumulation to potentiate cervical cancer cells immune escape.

Xiong J, He L, Chai X, Zhang Y, Sun S Cell Death Dis. 2024; 15(11):843.

PMID: 39557826 PMC: 11573975. DOI: 10.1038/s41419-024-07128-0.

References

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

de la Cruz-Lopez K, Castro-Munoz L, Reyes-Hernandez D, Garcia-Carranca A, Manzo-Merino J . Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches. Front Oncol. 2019; 9:1143. PMC: 6839026. DOI: 10.3389/fonc.2019.01143. View

Jin L, Chun J, Pan C, Alesi G, Li D, Magliocca K . Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis. Oncogene. 2017; 36(27):3797-3806. PMC: 5501759. DOI: 10.1038/onc.2017.6. View

Shen M, Zhao X, Zhao L, Shi L, An S, Huang G . Met is involved in TIGAR-regulated metastasis of non-small-cell lung cancer. Mol Cancer. 2018; 17(1):88. PMC: 5948872. DOI: 10.1186/s12943-018-0839-4. View

Kwon O, Bang I, Choi S, Jeon J, Na A, Gao Y . LDHA Desuccinylase Sirtuin 5 as A Novel Cancer Metastatic Stimulator in Aggressive Prostate Cancer. Genomics Proteomics Bioinformatics. 2022; 21(1):177-189. PMC: 10372916. DOI: 10.1016/j.gpb.2022.02.004. View

Icard P, Loi M, Wu Z, Ginguay A, Lincet H, Robin E . Metabolic Strategies for Inhibiting Cancer Development. Adv Nutr. 2021; 12(4):1461-1480. PMC: 8321873. DOI: 10.1093/advances/nmaa174. View

Shi L, Yan H, An S, Shen M, Jia W, Zhang R . SIRT5-mediated deacetylation of LDHB promotes autophagy and tumorigenesis in colorectal cancer. Mol Oncol. 2018; 13(2):358-375. PMC: 6360364. DOI: 10.1002/1878-0261.12408. View

Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli J . Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006; 91(8):2892-9. DOI: 10.1210/jc.2005-2838. View

Schweppe R, Klopper J, Korch C, Pugazhenthi U, Benezra M, Knauf J . Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab. 2008; 93(11):4331-41. PMC: 2582569. DOI: 10.1210/jc.2008-1102. View

10.

Hou X, Shi X, Zhang W, Li D, Hu L, Yang J . LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma. Cell Death Dis. 2021; 12(4):347. PMC: 8017009. DOI: 10.1038/s41419-021-03641-8. View

11.

Kang S, Bang J, Kang K, Lee H, Chung J . FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma. PLoS One. 2019; 14(6):e0218416. PMC: 6592523. DOI: 10.1371/journal.pone.0218416. View

12.

Sheng C, Chen H, Wang B, Liu T, Hong Y, Shao J . NAD(+) administration significantly attenuates synchrotron radiation X-ray-induced DNA damage and structural alterations of rodent testes. Int J Physiol Pathophysiol Pharmacol. 2012; 4(1):1-9. PMC: 3328394. View

13.

Xing M, Haugen B, Schlumberger M . Progress in molecular-based management of differentiated thyroid cancer. Lancet. 2013; 381(9871):1058-69. PMC: 3931461. DOI: 10.1016/S0140-6736(13)60109-9. View

14.

Augoff K, Hryniewicz-Jankowska A, Tabola R . Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer. Cancer Lett. 2014; 358(1):1-7. DOI: 10.1016/j.canlet.2014.12.035. View

15.

Thakur S, Daley B, Gaskins K, Vasko V, Boufraqech M, Patel D . Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer and . Clin Cancer Res. 2018; 24(16):4030-4043. PMC: 6095745. DOI: 10.1158/1078-0432.CCR-17-3167. View

16.

Huang J, Gao W, Liu H, Yin G, Duan H, Huang Z . Up-regulated ANP32E promotes the thyroid carcinoma cell proliferation and migration via activating AKT/mTOR/HK2-mediated glycolysis. Gene. 2020; 750:144681. DOI: 10.1016/j.gene.2020.144681. View

17.

Li L, Liang Y, Kang L, Liu Y, Gao S, Chen S . Transcriptional Regulation of the Warburg Effect in Cancer by SIX1. Cancer Cell. 2018; 33(3):368-385.e7. DOI: 10.1016/j.ccell.2018.01.010. View

18.

Robbins R, Wan Q, Grewal R, Reibke R, Gonen M, Strauss H . Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab. 2005; 91(2):498-505. DOI: 10.1210/jc.2005-1534. View

19.

Wang W, Larson S, Tuttle R, Kalaigian H, Kolbert K, Sonenberg M . Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine. Thyroid. 2002; 11(12):1169-75. DOI: 10.1089/10507250152741028. View

20.

Zhao D, Zou S, Liu Y, Zhou X, Mo Y, Wang P . Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. Cancer Cell. 2013; 23(4):464-76. PMC: 3885615. DOI: 10.1016/j.ccr.2013.02.005. View